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What is the key question? Are healthcare workers (HCWs) at increased risk of TB due to
occupational exposure in the UK?
What is the bottom line? Although HCW in the UK have an overall higher incidence of TB than non-
HCW, they do not have a higher incidence after stratifying by country of birth; this, combined with
the evidence of very few transmission events in the healthcare setting, suggests that TB in HCW in
the UK is not generally acquired through UK occupational exposure.
Why read on? This is the first national study of TB in HCW in the UK which is able to investigate the
incidence of TB in HCW in the UK after adjusting for country of birth, and incorporating genotyping
data on recent transmission events; the findings have important implications for occupational health
guidance on the prevention of TB in HCW.
2Abstract
Objectives: To describe the burden of TB in healthcare-workers (HCWs) in the UK and determine
whether HCWs are at increased risk of tuberculosis (TB) due to occupational exposure.
Methods: Retrospective cohort analysis of national UK TB surveillance and genotyping data between
2009 and 2013. The rate of TB in HCWs compared to non-HCWs, to calculate incidence rate ratios
stratified by country of birth.
Results: 2,320 cases of TB in HCWs were notified in the study period, 85% were born abroad. The TB
rate in HCWs was 23.4 (95% confidence interval (CI) 22.5-24.4) per 100,000 compared with 16.2
(95% CI 16.0-16.3) per 100,000 in non-HCWs. After stratifying by country of birth, there was not an
increased TB incidence in HCWs for the majority of countries of birth, including in the UK born..
Using combined genotyping and epidemiological data, only ten confirmed nosocomial transmission
events involving HCWs were identified between 2010 and 2012. Of these only two involved
transmission to patients.
Conclusions: The lack of an increased incidence of TB after stratifying by country of birth, and the
very few transmission events involving nosocomial transmission in the UK suggests that TB in HCWs
in the UK is not generally acquired through UK occupational exposure. The majority of cases in
foreign-born HCWs are likely to result from reactivation of latent TB infection (LTBI) acquired
abroad, and is not likely to be prevented by BCG vaccination in the UK. Testing and treatment of LTBI
in HCWs with exposure to high TB burden countries should be the focus of occupational health
prevention activities.
3INTRODUCTION
Tuberculosis (TB) in healthcare-workers (HCWs) has implications for public health and occupational
health. HCWs are at potential risk of infection from occupational exposure,(1) and active pulmonary
disease in HCWs presents a risk of nosocomial transmission to colleagues and patients. In the UK, a
study in the 1990s identified an increased risk of TB in HCWs compared to the general population,(2)
although this study did not adjust for country of birth, the most important risk factor for TB in the
UK. A previous small local study of 26 HCW cases in the West Midlands reported that most of this
increased risk may be associated with reactivation of disease acquired overseas.(3) Since these
studies were carried out the epidemiology of TB in the UK has changed, with a substantial increase in
case numbers, mostly among the foreign-born population from high TB incidence countries.(4) HCW
recruitment trends have also changed during this time, with a large number of HCWs recruited from
abroad.(5)
In the UK, guidelines recommend that all new employees working in a healthcare setting who will be
in contact with patients should be given pre-employment screening using a Mantoux test and/or an
interferon gamma release assay test.(6, 7) In all those who screen negative and are previously
unvaccinated, the guidelines recommend that Bacillus Calmette-Guerin (BCG) should be given.
To inform the continued relevance of existing occupational health guidance, an understanding of the
current burden of TB in HCW in the UK and assessment of the extent to which this is acquired due to
occupational exposure in the UK is required. In this study, we use national TB surveillance data to
describe the epidemiology of TB in HCW in the UK, and compare the incidence of TB in HCWs and
non-HCWs after stratifying by country of birth. In addition, we use a combination of genotyping data
and data on epidemiological links between cases to assess the extent to which HCWs have been
involved in recent transmission events in healthcare settings.
4METHODS1
Study population2
TB cases aged between 16 and 64 years, fulfilling the definition outlined for national surveillance,(8)3
with known occupation notified in the UK between 2009 and 2013 were included in the analysis.4
Patients were classified as HCWs or non-HCWs following the World Health Organization definition of5
a health service provider working in the health industry engaged in the promotion, protection or6
improvement of the health of the population excluding health management and support workers.(9)7
8
Notified TB cases were identified through the Enhanced TB Surveillance System in England, Wales9
and Northern Ireland and Enhanced Surveillance of Mycobacterial Infections in Scotland. The10
occupation recorded for notified cases was used to identify HCWs. HCWs were also classified into11
further occupational subcategories where possible, which were: doctor, nurse, healthcare assistant,12
or other. The following additional data were used: patient demographic characteristics (age, sex,13
ethnicity, country of birth, and time since entry to the UK grouped as five or less years before14
diagnosis (≤5) or more than five years before diagnosis (>5)) and clinical characteristics (site of 15 
disease, previous TB, time from symptom onset to treatment start for pulmonary cases, and BCG16
vaccination). TB outcomes were also collected at 12 months and reported for cases notified between17
2009 and 2012.18
19
Rates of TB in HCWs by country of birth were calculated using 2011 Office for National Statistics20
Census population estimates by occupational breakdown as the denominator (10). Rates of TB in21
non-HCWs by country of birth were calculated by subtracting the HCW population estimates from22
overall National Statistics Census population estimates in those aged 16 to 64 years (11). The rates of23
TB over the five years study period were calculated by dividing the total number of TB cases by the24
Census population estimates multiplied by five. Denominator data by occupational group was not25
available for Northern Ireland and Scotland, therefore all rates presented are for England and Wales26
only (which accounted for 94.5% of TB cases in the study population).27
28
TB case notifications were matched to Mycobacterium tuberculosis complex (MTBC) culture positive29
laboratory isolates received from the Mycobacterium Reference Laboratories for the relevant time30
period to collect drug susceptibility and 24 loci mycobacterial interspersed repetitive unit-variable31
number tandem (MIRU-VNTR) strain typing results. Matching was conducted using the Enhanced32
Matching System.(12)33
34
Statistical Analysis35
Demographic and clinical differences between HCWs and non-HCWs were compared using the Chi36
squared test, p-value of less than 0.05 was considered to be statistically significant. Incidence rate37
ratios were calculated comparing the incidence of TB in HCWs with non-HCWs; 95% confidence38
intervals were derived based on a Poisson distribution. All analysis was conducted using Stata 13.1.39
40
Assessment of recent transmission in England, Wales and Northern Ireland41
For HCWs with culture confirmed TB notified in England, Wales and Northern Ireland between 201042
and 2012, 24 loci MIRU-VNTR strain type clustering was used to identify any possible nosocomial43
transmission events. Since 2010, all culture confirmed TB cases have been strain typed using MIRU-44
VNTR.(13) A cluster of two or more cases with the same strain type may represent recent45
5transmission, or could be due to common endemic strain types in circulation in the UK or abroad. To1
establish whether a strain type cluster was likely to represent recent transmission, epidemiological2
investigation of all strain typing clusters containing a HCW was recommended between 2010 and3
2012.(13)4
5
Using a combination of strain typing and epidemiological data on links between cases, cases were6
classified as having been involved in a confirmed, probable, possible or refuted transmission event.7
Two cases with an epidemiological link and an indistinguishable 24 loci MIRU-VNTR profile (or with8
an indistinguishable profile, but with one case only typed to 23 loci) were defined as having been9
involved in a confirmed transmission event. Two cases with an epidemiological link and an10
indistinguishable MIRU-VNTR profile, but where one or both cases were not typed to 23 loci were11
defined as probable transmission. Two cases with an epidemiological link where one or both did not12
have a MIRU-VNTR profile were defined as possible transmission, and two cases with an13
epidemiological link but with distinguishable MIRU-VNTR profiles (one or more loci different) were14
defined as refuted transmission.15
6RESULTS1
Between 2009 and 2013, 34,573 TB cases aged 16 to 64 were notified in the UK. Occupation was2
recorded for 86.8% (30,001/34,573) of these cases. Where occupation was recorded, 7.7% (2,320)3
were HCWs. The proportion of TB cases recorded as HCWs each year remained stable (between 7%4
and 8%) over the five year period.5
6
Demographic Characteristics7
Compared to non-HCWs a higher proportion of HCWs were female (68.9%; 1,581/2,295 vs 40.4%;8
11,155/16,488), aged 25 to 44 years (70.2%; 1,628/2,320 vs 55.1%; 15,249/27,680) and foreign-born9
(85.0%; 1,893/2,227 vs 77.3%; 20,937/27,075) (Table 1). HCWs were born in 86 different countries,10
with 81.9% (1,788/2,182) originating from only ten countries (Table 2).11
12
Table 1. Basic demographics of TB cases in HCWs and non-HCWs13
HCW TB cases
(n=2,320)
Non HCW TB cases
(n=27,681)
Chi
squared p-
value
n % n %
Sex n=2,295 n=27,643
Male 714 31.1 16,488 59.6 p<0.001
Age group (years) n=2,320 n=27,681
16-24 126 5.5 5,213 18.8 p<0.001
25-34 785 33.8 9,273 33.5
35-44 843 36.4 5,976 21.6
45-54 400 17.2 4,161 15.0
55-64 166 7.1 3,057 11.0
Country of birth n=2,182 n=26,658
UK 334 15.3 6,138 23.0 p<0.001
India 559 25.6 5,913 22.2
Pakistan 128 5.9 3,860 14.5
Somalia 31 1.4 1,535 5.8
Nigeria 106 4.9 660 2.5
Nepal 74 3.4 654 2.4
Zimbabwe 200 9.2 459 1.7
Philippines 249 11.4 322 1.2
Kenya 44 2.0 331 1.2
South Africa 63 3.0 159 0.6
All other countries 394 18.1 6,627 24.9
Ethnicity n=2,252 n=27,201
White 270 12.0 4,824 17.7 p<0.001
Black African 644 28.6 4,936 18.0
Black Caribbean 45 2.0 555 2.0
Black Other 18 0.8 247 0.9
Indian 670 26.6 7,201 26.5
Pakistani 171 7.6 4,810 17.7
Bangladeshi 24 1.1 1,169 4.3
Chinese 23 1.0 378 1.4
Mixed / Other 387 17.2 3,081 11.3
Years since entry to the UK n=1,633 n=18,906
<2 161 9.8 4,188 22.2 p<0.001
2-5 473 29.0 5,825 30.8
6-10 624 38.4 3,840 20.3
>10 375 22.9 5,053 26.7
Site of disease n=2,312 n=27,611
Pulmonary 1,005 43.5 14,423 52.2 p<0.001
Extrapulmonary only 1,307 56.5 13,188 47.8
Social risk factor n=1,852 n=22,221
7Yes 43 2.3 2,754 12.4 p<0.001
Previous diagnosis n=2,219 n=26,502
Yes 97 4.4 1,687 6.4 p<0.001
BCG vaccination* n=1,665 n=19,356
Yes 1,456 87.5 14,282 73.8 p<0.001
Time to treatment start (pulmonary cases) n=765 n=10,631
<2 months after symptom onset 337 44.0 4,885 45.9 p=0.162
2-4 months after symptom onset 214 28.0 3,101 29.2
>4 months after symptom onset 214 28.0 2,645 24.9
Clustered (≥2 indistinguishable 24 loci 
MIRU-VNTR) n=883 n=11,554
Yes 423 48.0 6,402 55.4 p<0.001
MDR-TB n=1,425 n=17,226
Yes 20 1.4 285 1.7 p=0.473
* At any time1
2
Table 2. Risk of TB in HCWs by most frequent country of birth3
Country of Birth
n HCW TB
cases
(population
denominator*)
n Non-HCW TB
cases
(population
denominator*)
% HCW TB
cases**
Rate of TB in
HCW per
100,000
(95% CI)
Rate of TB in
non-HCW per
100,00
(95% CI)
Incidence
rate ratio
(95% CI)
All~ 2,320(1,983,571)
27,681
(34,290,136) 7.7
23.4
(22.5-24.4)
16.1
(16.0-16.3)
1.5
(1.4-1.5)
India 559(55,466)
5,913
(470,349) 8.6
201.6
(185.2-219.0)
251.4
(245.1-257.9)
0.8
(0.7-0.9)
UK 334(1,550,756)
6,138
(28,689,940) 5.2
4.3
(3.9-4.8)
4.3
(4.2-4.4)
1.0
(0.9-1.1)
Philippines 249(40,187)
322
(64,071) 43.6
123.9
(109.0-140.3)
100.5
(89.8-112.1)
1.2
(1.0-1.5)
Zimbabwe 200(24,503)
459
(77,207) 30.3
163.2
(141.4-187.5)
118.9
(108.3-130.3)
1.4
(1.2-1.6)
Pakistan 128(13,923)
3,860
(395,444) 3.2
183.9
(153.4-218.6)
195.2
(189.1-201.5)
0.9
(0.8-1.1)
Nigeria 106(27,289)
660
(139,454) 13.8
77.7
(63.6-94.0)
94.7
(87.6-102.2)
0.8
(0.7-1.0)
Nepal# 74 654 10.2 - - -
South Africa 63(13,900)
159
(146,808) 28.4
90.6
(70.0-116.0)
21.7
(18.4-25.3)
4.2
(3.2-5.5)
Kenya 44(10,703)
331
(106,091) 11.7
82.2
(59.7-110.4)
62.4
(55.9-69.5)
1.3
(1.0-1.8)
Somalia 31(2,937)
1,535
(79,288) 2.0
211.1
(143.4-299.6)
387.2
(368.1-407.1)
0.5
(0.4-0.8)
All other
countries
394
(243,907)
6,627
(4,121,484) 5.6
32.3
(29.2-35.7)
32.2
(49.3-51.7)
1.0
(0.9-1.1)
* For a single year4
** Proportion of TB cases from each country which are HCWs5
# Population estimates not available for Nepal so rates and incidence rate ratio could not be calculated6
~ Includes those with unknown country of birth7
8
Of the UK-born HCWs, the majority (61.1%; 203/332) were of White ethnicity, comparable to the9
proportion (58.8%; 3,556/6,052) in non-HCWs. The age distribution of UK-born HCWs differed to10
non-UK-born HCWs; only 54.2% (181/334) of UK-born HCWs were aged 25 to 44 years of age11
compared to 72.7% (1,376/1,893) in non-UK-born HCWs.12
13
Further occupational information was available for 56.3% (1,307/2,320) of HCWs. The majority of14
these were nurses (41.9%; 547), doctors (31.7%; 414) or healthcare assistants (19.8%; 259); other15
8occupational sub-groups contributed a low proportion (6.7%; 87) of cases. Place of birth (UK/non-1
UK) did not vary by occupation.2
3
Clinical Characteristics4
87.4% (1,456/1,665) of HCWs had been BCG vaccinated compared to 73.8% (14,282/19,356) of non-5
HCWs (Table 1). There was no difference in the time between symptom onset and treatment6
initiation for HCWs with pulmonary disease compared to non-HCWs; however it is noteworthy that a7
high proportion of HCWs (28.0%; 214) were symptomatic for longer than four months. Treatment8
completion was higher in HCWs compared to non-HCWs (83.8% vs 79.6% p<0.001) with a lower9
proportion of deaths (1.0% vs 1.9% p=0.001) and cases lost to follow-up (2.3% vs 4.6% p<0.001).10
11
Twenty HCWs had multidrug resistant TB (MDR-TB), the majority of which (75%; 15) had extra-12
pulmonary disease only and none were UK-born.13
14
Incidence of TB15
The overall incidence of TB in HCWs during this time period was 23.4 (95% CI: 22.5-24.4) per16
100,000, compared to 16.2 (95% CI: 16.0-16.3) per 100,000 in non-HCWs (incidence rate ratio 1.517
(95% CI: 1.4-1.5)). On stratification by country of birth, the incidence of TB was not higher in HCWs18
for the majority of countries of birth (Table 2). Importantly, UK-born HCWs did not have a higher19
incidence than UK-born non-HCWs, and for the other countries of birth contributing significant20
numbers of HCW TB cases (>100 cases over the study period), only those born in the Philippines or21
Zimbabwe had an incidence in HCWs that was higher than in non-HCWs (Table 2).22
23
The incidence of TB was found to differ between specific HCW occupational groups with the highest24
rate observed in doctors (41.2 (95% CI: 37.2-45.5) per 100,000), followed by nurses (19.5 (95% CI:25
17.8-21.3) per 100,000). In non-UK-born doctors the rate was 86.0 (95% CI: 76.9-96.0) per 100,00026
and in nurses 68.5 (95% CI: 62.1-75.4) per 100,000.27
28
Recent transmission in the UK29
Between 2010 and 2012, 45.8% (306/667) of HCWs with a culture confirmed strain typed MTBC30
isolate had the same strain type as at least one other TB case within the three year period. These31
HCWs were in 238 different molecular clusters which ranged in size from 2-131 cases. 53.8% of the32
clusters contained less than 5 cases. Following cluster investigation, only 24 of these HCWs were33
identified as having been involved in a confirmed transmission event in the UK, with a total of 2834
epidemiological links identified between a HCW and another TB case, or between two HCWs. The35
majority of the epidemiological links were between a HCW and a household contact (17), followed36
by 10 epidemiological links in a healthcare setting. One case had an epidemiological link in an37
unknown setting.38
39
The ten epidemiological links in healthcare settings represented eight confirmed transmission events40
(Figure 1). Six were between a HCW and a patient; in four of these instances the patient was41
identified as the HCW's source of infection. In the other two instances the same HCW was identified42
as the source of infection for two patients. The remaining four links in a healthcare setting were two43
separate instances of two HCWs who were contacts at work. Of the links identified in healthcare44
settings, the majority (75.0%; 6/8) involved UK-born HCWs.45
91
A further four HCWs were found to have been involved in probable transmission, three of these2
involved probable transmission with household contacts and one between work contacts. 533
possible transmissions were identified involving 49 HCWs. The majority (48) of these were between4
household cases, four were between two sets of work contacts and one was with a social contact.5
Five epidemiological links had transmission refuted following strain typing; none of these involved6
epidemiological links in healthcare settings.7
8
Ten out of 13 MDR-TB cases in HCWs which occurred between 2010 and 2012 had a unique strain9
type. Of the three which did cluster with another case, all were Indian-born and were each in10
different clusters; within these clusters no epidemiological links between the clustered cases were11
identified.12
10
DISCUSSION
This large retrospective cohort study shows there is a significant burden of TB in HCWs in the UK,
with more than 400 cases per year over the five year study period, accounting for nearly 8% of
working-age TB cases. The demographic characteristics of HCWs with TB compared with non-HCW
reflect the characteristics of the HCW population, with a disproportionate number of HCWs being
female, foreign-born, and aged between 25 and 44 years.
Our study is the first to estimate the risk of TB in HCWs across the UK by country of birth, and to
investigate the molecular epidemiology of TB in HCWs in the UK to assess whether cases were likely
to have been involved in a recent transmission event. Consistent with a previous national study,(2)
we found that the overall incidence of TB in HCW was significantly higher than in non-HCWs.
However, our study found that this increased incidence was no longer observed once country of
origin, the most important risk factor for TB in the UK, was accounted for, a factor which was not
adjusted for in the previous national study. Importantly, the incidence of TB in UK-born HCWs was
not raised compared to the general working-age UK-born population, nor was it raised for HCWs
born in most of the other countries of origin with significant numbers of HCW TB cases (India,
Pakistan and Nigeria).. This suggests that occupational exposure is not a significant risk factor for TB
in HCWs in the UK, and is consistent with a previous local study conducted in the West Midlands of
England in 1992 to 1995 which also identified no increased risk of TB in doctors from the Indian
Subcontinent ethnic group compared to the working-age population from the same ethnic group
and corresponding socio-economic status.(3) The incidence of TB was only raised in HCWs compared
to the general working-age population for those born in a small number of countries (the
Philippines, South Africa, Zimbabwe and Kenya); the type of migration from these countries (South
Africa and Zimbabwe) over the past decades means that HCWs from these countries do not
necessarily have a higher TB incidence than those of a similar socio-demographic background. Both
South Africa and Zimbabwe have a high rate of TB-HIV co-infection,(14) with a particularly high HIV
burden in females in the reproductive age group.(15,16) Recruitment of HCWs from South Africa and
Zimbabwe to the UK has predominantly been of nurses, likely to be young females. This may in part
explain the higher risk identified for South African and Zimbabwean HCWs compared to other
migrants from these countries.
The results of MIRU-VNTR strain typing showed that 46% of cases were part of a strain typing
cluster, lower than the overall proportion of TB cases that are in a cluster nationally (54%).(4) A large
proportion of clustered TB cases in the UK are thought not to represent recent transmission,
especially in the foreign-born population, where much of the observed clustering is likely to reflect
common endemic strains in patients’ countries of origin. Additional information on epidemiological
links identified through cluster investigation is required to demonstrate recent transmission in the
UK. Cluster investigation between 2010 and 2012 identified very few epidemiological links for HCWs
cases that were part of a strain typing cluster. Of the 667 culture confirmed cases with a strain type,
only eight were identified as having been involved in a confirmed nosocomial transmission event, of
which four involved patient to HCW transmission, two involved HCW to HCW transmission, and two
events involved transmission from one HCW to two separate patients. The finding of low
transmission within health settings is supported by previous UK findings of a very low yield of
11
additional TB cases during extensive contact tracing exercises.(17) Of the four HCWs who are likely
to have acquired their infection through occupational exposure in the UK, with a molecular and
confirmed epidemiological link to a symptomatic patient, all were UK-born. Similarly, a study from
the Netherlands (another low TB incidence country), found that all HCWs likely to have acquired TB
due to nosocomial transmission within the country were native-born.(1) This suggests foreign-born
cases predominantly acquired infection abroad or, in a more limited number of cases, due to
household transmission in the community.
The finding of no increased risk of TB in HCW compared to non-HCW after stratifying by country of
birth for all but two countries of birth, combined with the very small number of cases with a
molecular and epidemiological link consistent with nosocomial transmission, suggests that TB
diagnosed in HCWs in the UK is generally not acquired as a result of UK occupational exposure. Given
that the vast majority of TB in HCWs (more than 82%) occurs in those born abroad in high TB burden
countries, it is likely that the majority occur due to reactivation of latent TB infection (LTBI)
contracted in their country of origin. This has clear implications for occupational health policies. For
HCWs from high TB burden countries, exposure and infection is likely to have already occurred prior
to UK entry and occupational health assessment, so BCG vaccination in those without evidence of
prior infection, as recommended in current guidance,(6,7) is likely to be of little benefit to the
general HCW population.(18,19) As speciality and location of HCWs place of work was not known,
our study does not provide information on whether those at high risk of occupational exposure to TB
patients (e.g. those working in TB clinics) have a higher incidence of TB, and for whom BCG
vaccination may still be warranted.
Following existing guidance, all HCWs should be screened for LTBI as part of pre-employment health
checks.(6,7) This action, and the provision of treatment of LTBI for those found to be latently
infected, is likely to be most effective at preventing active cases of TB in HCWs, and any subsequent
transmission. It is particularly important to ensure that HCWs from high TB burden countries are
appropriately screened.
There was no difference found between the length of time between symptom onset and treatment
start for HCWs with pulmonary TB compared to non-HCWs, despite presumed access to
occupational health departments and better knowledge about TB symptoms. As nearly a third (28%)
of HCWs with pulmonary disease were symptomatic for more than four months before starting
treatment, additional awareness raising of the signs and symptoms of TB, including in those who
have been treated for LTBI, is important to ensure that any HCW who develops active disease
presents to healthcare quickly.
Our study has a number of strengths. We used the full cohort of TB cases notified to national
surveillance systems in the UK over the study period, so will have captured the vast majority of TB
cases that occurred in this time period. Data completion for the occupation field was high (86%), and
we were able to use national population data on occupational breakdown as our denominator.
Unlike the previous national study of TB in HCW conducted in the UK,(2) we were able to stratify our
incidence rate ratios by country of birth, which is the strongest risk factor for TB in the UK. In
12
addition, we were able to use MIRU-VNTR strain typing and data on epidemiological links between
cases obtained through cluster investigations to investigate recent transmission events.
Our study also has some limitations. Although we stratified our incidence ratios by country of birth,
which is by far the most important risk factor for TB in the UK, we were not able to adjust for all the
factors identified to differ between HCWs and non-HCWs such as age, sex and social risk factors, as
these breakdowns were not available along with country of birth and occupation in the denominator
data. HIV status was not known for the TB cases in our study, and is likely to be a contributing factor
in many of the cases from sub-Saharan Africa, with a previous UK study showing 14% of HCWs with
TB from these countries were co-infected with HIV.(8) In addition, the speciality and location of
HCWs place of work was not known, so we were not able to assess whether there is an increased
risk of TB in those working in settings where they are more likely to be exposed to TB. Although
cluster investigations were conducted to search for epidemiological links in strain type clusters
containing HCWs, some links may not have been identified. In addition, non-culture confirmed cases
without an otherwise apparent epidemiological link in a healthcare setting would not have been
routinely investigated, so nosocomial transmission involving HCWs may have been underestimated.
However, the fact that so few epidemiological links in healthcare settings were discovered during
active cluster investigation supports the conclusion that nosocomial transmission involving HCWs in
the UK is very rare.
In conclusion, the occurrence of large numbers of cases of TB in HCWs in the UK highlights the need
to strengthen occupational health practices for the prevention and early identification of TB in the
UK. The lack of evidence of an increased risk of TB among HCWs in the UK, the evidence of only very
rare occurrences of nosocomial transmission in the UK, and the majority of HCW TB cases originating
from high TB burden countries likely reactivating from latent infection, suggests guidelines on the
prevention of TB in HCWs should focus less on preventing infection through BCG vaccination, and
more on identifying and treating LTBI, especially in HCWs from high TB burden countries.
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